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CHAPTER I
INTRODUCTION
Retrospective self report data is often used for a wide range of research
purposes, and is especially prominent in the behavioral and medical fields. This
method of self report has been particularly useful in research of the illness
commonly referred to as myalgic encephalomyelitis/chronic fatigue syndrome
(ME/CFS). The precise definition of ME/CFS is often debated, but the most
widely used case definition stipulates that to meet criteria for the illness, a person
must have experienced six or more months of chronic fatigue of new or definite
onset, that is not substantially alleviated by rest, not the result of ongoing
exertion, and that results in substantial reductions in occupational, social, and
personal activities (Fukuda, et al., 1994). Furthermore, a person must have four
out of eight accompanying symptoms (e.g. sore throat, lymph node pain, muscle
pain, joint pain, post-exertional malaise, headaches of a new or different type,
memory and concentration difficulties, and unrefreshing sleep) that have also
persisted for at least six months or longer (Fukuda et al., 1994). Retrospective self
report methods are often used in research settings to determine whether an
individual has experienced the required fatigue and accompanying symptoms for
the length, frequency, and severity necessary to receive a diagnosis of ME/CFS
(Hawk et al., 2007; Jason et al., 1999; King & Jason, 2005; Reeves et al., 2005).
More generally, self report data can help researchers and health care
personnel gain information about the health status and quality of life of
individuals suffering from various health problems, medical conditions and
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chronic illnesses. Retrospective data have proved to be very useful because it is
less costly and time intensive than prospective, longitudinal studies and allows
researchers and health professionals to gather information about events that may
have occurred weeks, months, or years prior to participation in a research study or
formal health evaluation (Beckett, Da Vanzo, Sastry, Panis, & Peterson, 2001).
Although there is clear utility in using retrospective self report data to assess
health status, retrospective surveys (no matter how simple the question) often
require complex mental processes. For instance, when a respondent is confronted
with a question that asks about a past event, he/she implicitly goes into a series of
steps in order to recall the information. The respondent must process and interpret
the question, evaluate the question in terms of his/her individual knowledge and
the general scope of the survey, understand the interviewer or administrator‟s
expectations, and evaluate the response in terms of its social desirability
(Bradburn, Rips, & Shevell, 1987).
Research on these psychological processes and their potential effects on
the validity and reliability of survey data suggest that researchers need to be
careful when designing and evaluating studies that involve retrospective methods
for gathering information. Specifically these processes can contribute to the
phenomenon known as recall bias, which occurs when the ability to accurately
and reliably report an event is dependent on the strength of the memory for the
event as well as environmental factors. For instance, if a person‟s memory for a
specific event is distorted in any way, it will be more difficult to accurately report
the event when asked to on a survey.
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It is particularly important to assess the phenomenon of recall bias for
health symptoms because the more a physician knows about a patient‟s
symptoms, the more information they have when developing effective treatment
plans. Furthermore, controlling for recall bias is especially important in the
assessment of symptoms experienced by individuals with ME/CFS. Currently,
ME/CFS is a poorly understood illness without any universally recognized
biological markers. Therefore, self-report measures are heavily relied on for
making diagnostic decisions. This reliance on patient report data allows for biases
that may ultimately decrease the reliability and validity of diagnostic assessments.
Furthermore, many measures used to assess health symptoms have varying
reporting periods (recall timeframes) and although research has found that recall
bias may increase with longer reporting periods, few studies have been conducted
in this area (Broderick et al., 2008). It may be especially important to understand
how varying reporting periods are more or less susceptible to recall bias when
assessing symptoms of ME/CFS. Many researchers are hopeful that an
improvement in the methods to diagnose the illness will lead to a more
homogenous illness group which in turn would make it easier for scientists to find
clear biological markers of the disease (Jason et al., 2010).
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Recall Bias: A General Overview
Specific biases that can occur in retrospective data include either
forgetting that an event ever occurred and thereby not reporting it on a survey
(omission), or misremembering an event as having occurred more recently in time
than it actually did (telescoping) (Sudman & Bradburn, 1973). Whether these
biases occur depends on a variety of factors that have to do with the
characteristics of the event, the way in which an individual perceives the event,
and the context in which an event is remembered (Stull, Leidy, Parasuraman, &
Chassany, 2009). Characteristics related to the event itself might include how
recent in time the event occurred in relation to the evaluation or assessment
(recency) as well as the complexity for the event in question. Furthermore, the
personal significance of an event (saliency) (Gendreau, Hufford, & Stone, 2003),
as well as the respondent‟s mood at the time an event is remembered (Stull,
Leidy, Parasuraman & Chassany, 2009), may also impact an individual‟s memory
for it. The degree to which certain factors will affect a person‟s memory for past
events, as well as the circumstances in which these factors are most influential,
are important for researchers to understand when designing and evaluating
research studies.
Timeframe and Recall Bias
Much of the current research on cognitive theory and recall bias has been
influenced by the early work of Ebbinghaus in 1885 and his influential “forgetting
curve.” Ebbinghaus famously demonstrated that the rate at which individuals
forget information is more pronounced immediately after an event has occurred,
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and that the degree of forgetting tends to plateau as more time goes by
(Ebbinghaus, 1913). This early work by Ebbinghaus has influenced more recent
studies looking at how the recency phenomenon influences our ability to
accurately remember events. Studies have shown that the longer the recall period,
the less accurate a person‟s memory is for distinctive and autobiographical events
(Bradburn et al., 1987; Skowronski, Betz, Thompson, & Shannon, 1991).
Furthermore, longer recall periods reduce response accuracy for hospitalizations,
health events, symptom onset, and overall morbidity (Amjadi-Begvand et al.,
2004; Celebrezze & Terry, 1965; Dedominicis & Grechi, 1965; Feikin et al.,
2010). Other studies, however, have found that longer recall periods do not
necessarily result in decreased accuracy or reliability. For instance, it has been
found that people can consistently report pain severity (Brauer, Thomsen, Loft, &
Mikkelson, 2003) as well as missed workdays (Rivicki, Irwin, Reblando, &
Simon, 1994) at one month and three month reporting periods. Additionally, it has
also been found that the Positive Affect-Negative Affect Scale (PANAS), has
excellent test-retest reliability across multiple timeframes (e.g. current, today, past
few days, past week, past few weeks, past year, general) (Watson, Clark, &
Tellegen, 1988; Watson & Clark, 1994).
Overall, more support has been garnered for greater inaccuracies as recall
period is increased, which might suggest that retrospective surveys should include
very short reporting periods. On the other hand, shorter reporting periods are not
without biases either. For instance, the phenomenon known as forward
telescoping happens more often with shorter reporting periods such as asking
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someone to recall information over the past week (Bradburn, 2000). Forward
telescoping occurs when a person reports events that occurred prior to the
reporting period designated on a survey item, and this in turn causes an
overreporting of events (Bradburn, 2000; Sudman & Bradburn, 1973). Biases
associated with longer reporting periods (e.g. the past six months; the past year)
are more likely to involve the phenomenon of forgetting, which in turn causes
omission of information and overall underreporting of events (Clarke, Fiebig,
Gerdtham, 2008; Sudman & Bradburn, 1973).
Some studies have found that an underreporting of events is more
common than overreporting. This phenomenon has been particularly recorded for
reports of health care utilization (Evans & Crawford, 1999). It has been suggested
that these over and underreporting biases may cancel each other out as long as the
optimal reporting period is utilized on a survey. This optimal reporting period
may be a timeframe that falls in between the extremely recent and very long
(Sudman & Bradburn, 1973), but it is still unclear how one decides what reporting
period is too long or too short. This issue may depend on other factors that have
been shown to influence our memory for past events (e.g. complexity, saliency,
and mood).
Recall Bias: Stability, Complexity, and Context
In addition to his research on the phenomenon of recency, Ebbinghaus
also discovered that the rate of forgetting depends on the characteristics of the
event or phenomena in question (Stull et al., 2009). For instance, events that are
fairly stable over time or those that happen once in a lifetime are remembered
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with greater ease than events that change and fluctuate over time (Stone &
Shiffman, 2002). When choosing what timeframe to use in a survey, it is
important to know as much about the phenomenon being measured as possible.
For instance, a short recall period may enhance information accessibility for the
specific time period, but if there is no stable pattern to the phenomena, a short
recall period might not capture the true nature of the symptom‟s variability over
time (Stone & Shiffman, 2002; Stull et al., 2009). Clarke et al. (2008) assert that
there is a tradeoff between reporting accuracy and loss of information when
deciding between a shorter or longer recall timeframe. Short timeframes may
increase the accuracy of recall, but investigators risk losing valuable information
about the true nature of the phenomena that would be better captured with a
longer recall period. In other words, a short timeframe is not always compelling
for certain phenomena and it is important to take variability and stability into
account when thinking about an optimal timeframe (Clark et al. 2008).
In the case of health symptoms, Stone and colleagues (2002) assert that
when someone reports about a highly variable symptom, they are making an
overall assessment of their experience, but cannot indicate the variable nature of
the symptom in such a short time period. However, when highly variable
symptoms are reported over longer timeframes, an individual will attempt to
summarize their experience, which can reduce reporting accuracy (Stone,
Schwartz, Broderick, & Shiffman, 2005). The complexity of recalled information
has been described by Converse and Presser (1986) and later by Reis and Gable
(2000) as information accessibility (as cited in Stull et al., 2009). Certain
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phenomena are accessed with greater ease than others. For instance the names of
medications are less accurately recalled compared to a person‟s memory for
hospitalization utilization (Evans & Crawford, 1999). Additionally, medical
conditions are harder to recall if a survey includes scientific terms used by
physicians rather than using more layman‟s terms for conditions (Madow, 1967);
a finding that highlights the importance of thoughtful planning for constructing
clear and culturally sensitive surveys.
Context can also have a profound effect on response bias. Context related
to recalled information refers to the personal and social meaning the information
has for the respondent, as well as how this information is perceived in the broader
environment (Stull et al., 2009). One specific contextual factor that can affect
recall accuracy is the saliency of the information being recalled. The saliency of a
recalled event has to do with its significance or personal relevance to the
respondent. In terms of recall bias, highly salient information is often recalled
more accurately than less salient information. This finding has been reported for
recall of major symptoms versus minor symptoms (Cannell, Marquis, & Laurent,
1977), for recall of pain intensity versus pain location (Dawson, Kanim, & Sra,
2002), and for recall of information when in in-patient hospitalization versus outpatient consultation (Stull et al., 2009).
Another factor affecting recall is the mood and health status of the
respondent at the time of an assessment or evaluation (Broderick, Schwartz,
Shiffman, Hufford, & Stone, 2003). Specifically, when people are in a negative
mood, they are more likely to access and recall information that is also negatively
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charged (Stull et al., 2009). This phenomenon of current mood bias is seen with
recall of affect and attitude (Blaney, 1986) as well as in medical research. For
instance, someone who is experiencing more pain during an assessment is more
likely to recall past pain symptoms as more severe than they had initially reported
at baseline (Eich et al., 1985).
Recall for Health Symptoms
Retrospective survey data is used in many different areas of study, but in
order to assess the accuracy and reliability of this type of data in the context of an
illness such as ME/CFS, it is important to understand recall bias that is associated
with specific health symptoms. Two symptoms that are commonly cited in the
recall literature and that are frequently experienced by individuals with ME/CFS
are pain and fatigue.
Pain has been studied under a variety of different contexts, including
rheumatoid arthritis (Stone, Broderick, Kaell, DelesPaul, & Porter 2000;
Broderick et al., 2008), chronic pain (Stone, Broderick, Shiffman, Litcher-Kelly,
& Calvanese, 2003; Stone et al., 2005), and the illness known as fibromyalgia
(Williams et al., 2004). In order to compare recalled pain with averaged
momentary pain assessments, researchers have used paper daily diaries, electronic
diaries, ecological momentary assessment (EMA) techniques, and a combination
of prospective and retrospective survey methods (McColl, 2004; Stull et al.,
2009). Within this literature, researchers have consistently found that there is a
tendency to recall higher pain levels than were previously reported at baseline.
Stone, Broderick, Shiffman, and Schwartz (2004) suggest that the discrepancy
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between recalled pain and momentary pain may be due to the tendency to only
recall salient pain events and to ignore periods where pain is not experienced as
intensely. Specifically, it has been shown that when attempting to make an overall
pain assessment, patients are not merely averaging their pain; rather, they are
using cognitive heuristics in which they rely on aspects such as the variability of
the pain experience (Redelmeier, Katz, & Kahneman, 2003), peak periods of pain
over time (Stone et al., 2000), the most recent pain experiences (recency)
(Redelmeier et al, 2003; Stone et al., 2000), and/or a combination of peak and
recency known as “peak-end” (Kahneman, Fredrickson, Schreiber, & Redelmeier,
1993; Redelmeier, & Kahneman, 1996). Despite the discrepancy between
recalled pain and momentary pain, there is still a moderate correlation between
the two reporting periods and this moderate correlation might suggest to
researchers that either method is sufficient for assessing pain. However, when
changes in recalled pain and momentary pain are compared in a “within subjects”
design, the correlation is significantly lower (Stone et al., 2004). Furthermore, it
has been found that people with chronic pain who perceived their pain as
worsening over time, did not show a significant change in multiple reports of
momentary pain assessments (Stone et al., 2004).
Research on pain across different reporting periods suggests that when
patients are asked to recall pain, their recall accuracy weakens over the course of
seven days. However it was also found that correlations between recalled pain
ratings and momentary pain ratings were higher for a 28 day recall timeframe
compared to a seven day recall timeframe (Broderick et al., 2008). Broderick and

11

colleagues (2008) theorize that individuals with chronic illnesses may have a
good idea of their typical symptom pattern overtime, thus allowing them to make
an overall assessment of the last 28 days based on their symptom beliefs. This
explanation seems best to describe chronic symptoms that are fairly stable
overtime, but it is still unclear if pain that is fluctuating over a long period of time
would have a similar effect on recall. Beyond issues related to accuracy and
reporting length, Williams, Davies, and Chadury (2000) found that chronic pain
patients may not always be recalling pain severity, but may instead report on the
perceived impact that the pain has on functioning. Additionally, they found that
the way one respondent interprets a pain rating scale can be very different from
the way another person will (Williams et al., 2000). These results underscore the
subjective nature of pain as well as its multidimensionality.
A handful of studies have investigated issues of recall for chronic fatigue
and fatigue related to the illness ME/CFS (Broderick et al., 2008; Friedberg &
Sohl, 2008; Sohl & Friedberg, 2008). Similar to findings within the pain
literature, participants report experiencing higher levels of fatigue when it is
recalled retrospectively compared to multiple momentary fatigue assessments.
Despite this discrepancy, there is still a moderate to high correlation between a
person‟s retrospective rating of fatigue and the average of their momentary ratings
of fatigue (Broderick et al., 2008; Friedberg & Sohl, 2008). It has also been found
that the more variable the fatigue, the higher the discrepancy between recalled
fatigue and averaged momentary fatigue (Sohl & Friedberg, 2008); further
validating the proposed impact of symptom stability on recall accuracy.
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Much of the literature on recall bias for health related symptoms focuses
on general pain and fatigue. Only a couple of studies have assessed recall
accuracy for these symptoms in the context of the illness ME/CFS (Friedberg &
Sohl, 2008; Sohl & Friedberg, 2008). Furthermore, the authors of these studies
limited their investigation to the extent that retrospective recall correlates with
momentary recall (i.e. recall accuracy). The diagnostic measures used in research
can only be useful if they are shown to be both accurate and reliable (Spitzer,
Endicott, & Robins 1978); therefore, it is equally important to evaluate the effects
of varying timeframes on the reliability of recall for health symptoms.
Reliability of ME/CFS Symptom Ratings
A few studies have evaluated the test-retest reliability of specific
diagnostic instruments used in ME/CFS research (Hawk et al., 2007; Jason et
al.,1997). For instance, Hawk et al. (2007) investigated the issue of diagnostic
reliability and test-retest reliability of a CFS Questionnaire. The CFS
Questionnaire is a revised version of the CFS Screening Questionnaire developed
by Jason et al. (1997) and can be used as a diagnostic instrument based on the
Fukuda et al. (1994) criteria. In order to determine the sensitivity, specificity, and
reliability of the measure, Hawk and colleagues (2007) administered the measure
at two time points and to individuals with ME/CFS, major depressive disorder
(MDD), and to healthy controls. Items from the CFS Questionnaire assess aspects
of functioning and symptom experience and incorporate varying timeframes that
range from „the past day‟ to the „past six months.‟ Participants completed the CFS
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Questionnaire twice with two weeks in between each assessment and independent
raters evaluated each assessment to determine a diagnosis.
Based on evaluations from the independent raters, the researchers found
that the average test-retest reliability of the measure was very good, with most
intraclass correlation coefficients at .70 or higher; however, different items were
found to have better reliability scores than others. For instance, some items on the
CFS questionnaire were developed to assess the reported frequency and severity
of the eight ME/CFS case defining symptoms (fatigue/sickness following mental
or physical exertion, unrefreshing sleep, problems remembering or concentrating,
muscle aches and pains, joint pain, sore throat, tender lymph nodes/swollen
glands, and headaches) recalled over the past six months. Overall, the average
intraclass correlation scores for these items were very good (.77); however two
symptoms (tender/sore lymph nodes and pain in multiple joints) had somewhat
lower reliability scores (.58 and .49 respectively) (Hawk et al., 2007). Some
additional items also had lower test-retest reliability scores. For instance, items
asking participants to rate (on a scale of 0 to 100) their perceived energy, amount
of expended energy, and amount of fatigue experienced over the past 24 hours,
had lower reliability scores (.59, .40, and .22 respectively). Interestingly, these
same items were also recalled at a slightly longer timeframe (over the past week)
and resulted in better reliability scores (.77, .59, and .81 respectively). The authors
have suggested that these symptoms likely fluctuate often and can be more
consistently recalled over a longer timeframe. Furthermore, these results suggest
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that it is important to take into account the type of question being asked and the
timeframe in which it is asked when developing reliable diagnostic instruments.
The most widely used case definition for ME/CFS (Fukuda et al., 1994)
requires a person to have at least six months of disabling fatigue and also four out
of eight core symptoms (impaired memory or concentration, headaches, sore
throat, lymph node pain, muscle pain, joint pain, unrefreshing sleep, and postexertional malaise) also lasting six months or longer (Fukuda et al., 1994). This
definition has been criticized for being too vague and lacking objective criteria to
reliably classify individuals with ME/CFS (Jason et al., 2010). In order to
improve the objectivity and reliability of the diagnostic criteria, researchers have
recommended the use of standardized measures for charting and assessing
symptoms of ME/CFS (King & Jason, 2005).
The Centers for Disease Control and Prevention (CDC) has developed an
empirical case definition that assesses fatigue, the eight accompanying symptoms
of ME/CFS, and disability, using validated and standardized measures (Reeves et
al., 2005). The authors of the empirical case definition use the Symptom
Inventory (Wagner et al., 2005) to assess the occurrence, frequency, and severity
of the eight accompanying symptoms of ME/CFS recalled over the past month.
The Medical Outcomes Survey Short-Form-36 (SF-36) is used to assess
disability, and utilizes either a four-week recall timeframe or a one-week recall
timeframe (Keller et al., 1997). Lastly, the Multidimensional Fatigue Inventory
(MFI) is used to assess fatigue and requires participants to rate symptoms over the
previous days (Smets, Garssen, Bonke, & Haes, 1995).
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Each standardized measure included in the empirical case definition
employs different timeframes, and this is not uncommon in many research
studies. Some instruments used in research of health symptoms use multiple recall
timeframes on a single questionnaire and others do not even specify a timeframe
(Broderick et al., 2008). Furthermore, there is rarely any justification given for
why a particular timeframe is used (Broderick et al., 2008). Given, the strong
need for objective and reproducible ME/CFS criteria, it would be beneficial to
determine the degree to which varying timeframes impact recall for specific
ME/CFS symptoms.
The empirical case definition has received considerable controversy, as
some have found that the definition may erroneously include people with primary
psychiatric conditions and may lack the appropriate sensitivity for selecting
individuals with the illness (Jason, Najar, Porter, & Reh, 2009; Jason et al., 2010).
Although the empirical case definition may not become the staple of diagnosis
and assessment in ME/CFS research, many future efforts will likely be made to
establish an empirically derived case definition to improve the accuracy and
reliability of diagnoses; especially in the absence of unequivocal biological
markers.
Overall, researchers in the field have recommended that measures used to
chart and assess symptoms of ME/CFS be both comprehensive and sensitive to
the variability of symptom experience across individuals with this illness (Jason et
al., 1999). Also, it has been noted that differences in the criteria used to classify
individuals with ME/CFS accounts for the largest proportion of diagnostic
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unreliability (Jason, Helgerson, Torres-Harding, Carrico, & Taylor, 2003). In
order to decrease criterion variance and enhance diagnostic reliability, researchers
have suggested that ME/CFS criteria incorporate specific standardized
instruments to use as well as explicit guidelines regarding the number, frequency,
and severity of symptoms required for a diagnosis. In light of these issues as well
as the extensive reliance on self-report measures in ME/CFS research, the impact
of different recall timeframes should also be investigated when developing and
evaluating the diagnostic criteria for ME/CFS. Furthermore, it has been argued
that the validity and reliability of symptom recall is important for developing
appropriate treatments (Fienberg, Loftus, & Tanur, 1985). More research needs to
be done to determine the optimal recall length for assessing specific symptoms of
ME/CFS.
In sum, retrospective self-report measures are often used in research to
assess symptoms that are commonly reported by individuals with ME/CFS. This
reliance on patient report data allows for biases that may negatively impact the
reliability and validity of diagnostic and treatment decisions. Furthermore, many
measures used to assess ME/CFS symptoms have varying recall timeframes. It is
unclear what the optimal reporting period is for tracking health symptoms,
especially for a complex chronic illness such as ME/CFS where certain symptoms
may fluctuate overtime. Only a small number of studies have investigated the
issue of recall bias for symptoms of ME/CFS, and these studies limited their
investigation to the extent of agreement between patients‟ reports of momentary
fatigue versus fatigue that was recalled over a week-long timeframe (Friedberg &
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Sohl, 2008; Sohl & Friedberg, 2008). There are a few documented studies that
have assessed the test-retest reliability of an ME/CFS diagnostic instrument that
includes multiple timeframes for different items; however, to this authors‟
knowledge there are no reported studies in the ME/CFS literature that have
assessed the test-retest reliability of each case-defining symptom on a
standardized instrument across varying timeframes. For instance, Hawk, et al.
(2007) assessed test-retest reliability for the eight case-defining symptoms of
ME/CFS recalled over a six month timeframe; however, it is unclear whether testrest reliability would be stronger for these symptoms at shorter timeframes.
The ME/CFS literature is lacking information on the potential impact of
timeframe on symptom recall in individuals with ME/CFS. In response to this
lack of important psychometric information, this study served as an evaluation of
the test-retest reliability of a revised Symptom Inventory that includes four
different timeframes (right now, past week, past month, and past six months).
Research has shown that both short (e.g. past week) and long recall periods (e.g.
past six months) can negatively impact recall accuracy for health symptoms in
different ways. Furthermore, contextual factors such as symptom stability and
momentary symptom severity have also been found to impact reporting accuracy.
Very little research has been done on the ways varying timeframes and contextual
factors can influence the test-retest reliability of health symptom reports;
particularly in the context of ME/CFS.
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Statement of Hypotheses and Research Questions
Hypothesis I. ME/CFS symptoms will be recalled with greater consistency (yield
stronger reliability coefficients) when symptoms are perceived as stable over time
rather than variable.
Hypothesis II. An increase in momentary (right now) symptom severity ratings
from baseline to assessment two (occurring one week later) will significantly
predict an increase in past week, past month, and past six month symptom ratings
from baseline to assessment two. A decrease in momentary (right now) symptom
severity ratings from baseline to assessment two (occurring one week later) will
significantly predict a decrease in past week, past month, and past six month
symptom scores from baseline to assessment two.
Research Question Ia. Is there an optimal recall timeframe in terms of test-retest
reliability, for ME/CFS symptoms that are perceived as variable over time?
Supplemental Research Question 1b. Is there an optimal recall timeframe in terms
of test-retest reliability, for ME/CFS symptoms that are perceived as stable over
time?
Research Question II. Does the optimal recall timeframe in terms of test-retest
reliability, differ by the ME/CFS symptom being measured?
Research Question III. What is the optimal recall timeframe in terms of test-retest
reliability, for ME/CFS symptoms, in the absence of contextual factors (e.g.
symptom stability and momentary symptom severity)?
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CHAPTER II
METHOD
This section presents information on participant recruitment, study
procedures, and measurement tools. Data were collected over the phone at two
time points, from individuals with a current diagnosis of ME/CFS.
Participants
The study population consisted of 51 adults (45 women and 6 men),
between the ages of 29 and 66 (M= 50.39) with a current diagnosis of ME/CFS.
The majority of participants identified as White (94%), one participant identified
as Asian/Pacific Islander, and two identified as “other.” Two participants
identified as Latin/Hispanic origin. Approximately half of all participants were
married (N=27), 13 were never married, and 11 were divorced. The majority of
participants received a standard college degree or higher (70.6 %) and all 51
participants reported at least a high school degree. Over half of the participants
were on disability (58.8 %), with the large majority citing chronic fatigue
syndrome as the cited reason for their disability claim. Only one participant
reported working full-time and six reported working part-time. A large proportion
of participant diagnoses (78%) were confirmed with letters of documentation by
independent physicians. All 51 participants met criteria for the Fukuda et al.
(1994) case definition. Participants were identified through the use of an IRB
approved research advertisement published in an ME/CFS Chicago newsletter.
The current study group was also made up of individuals who participated in an
earlier non-pharmacological intervention at DePaul University‟s Center for
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Community Research (Brown & Jason, 2007). Participants received a five dollar
Amazon gift card upon completion of the study.
Procedure
Data collection occurred on two separate occasions with one week
between the first and second assessment. Researchers received verbal consent
from participants over the phone and scheduled two phone interviews. In order to
ensure that all participants completed the questionnaires under the same
conditions, the interviews took place over the phone and were scheduled with one
week in between the first and second interview, at the same time and on the same
day of the week. During the first interview, participants were not told that they
would be asked the same questions a week later, and instead were informed that
they would be taking another short symptom survey during the second interview.
This was to ensure that participant responses at the second interview were not
primed by the first.
During the first phone interview, participants were read questions aloud
from a revised Symptom Inventory (SI-R: See Appendix A) which was altered by
this author from the original Symptom Inventory developed by Wagner et al.
(2005). Participants were also read a Symptom Stability Survey (See Appendix
B), a short demographic survey, and a significant events questionnaire, all
developed by this author and others at DePaul University. Phone interviewers
repeated items for participants as necessary. During the second phone assessment,
participants were read items from the SI-R, the Symptom Stability Survey, and
the significant events questionnaire a second time. Following completion of the
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second phone assessment, participants were debriefed on the purposes of the
study.
Measures
All study measures were administered over the phone by IRB approved
graduate students and staff members at the Center for Community Research at
DePaul University. Interviewers read the same set of instructions to all
participants and recorded responses as they were given.
ME/CFS Symptom Assessment
The Symptom Inventory-Revised (SI-R) (see Appendix A) assesses the
presence, frequency and severity of the case-defining symptoms of ME/CFS
(post-exertional malaise, unrefreshing sleep, problems with memory and/or
concentration, muscle aches and pains, joint pain, sore throat, tender lymph
nodes/swollen glands, and headaches) according to Fukuda et al. (1994). The SI-R
is a revision of an earlier Symptom Inventory that was developed by the Center
for Disease Control and Prevention (CDC). The CDC‟s symptom inventory
assesses the frequency and severity of symptoms over the past month and has
been shown to have good internal consistency, with a Chronbach‟s alpha
coefficient of 0.88 for the total inventory score and 0.87 for the total score from
a short-form version, including only six symptoms (fatigue after exertion,
unrefreshing sleep, muscle aches, sleeping problems, problems with memory, and
problems with concentration). The CDC Symptom Inventory has also been found
to have excellent convergent validity with standardized measures of fatigue and
functioning (Wagner et al., 2005). For the purposes of this study, revisions to the
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Symptom Inventory included the addition of four timeframes: right now, past
week, past month, past six months. Additionally, participants‟ frequency and
severity ratings on the SI-R were multiplied to create a composite score for each
symptom at the past week, past month, and past six month intervals, with scores
ranging from 0 to 25 (Wagner et al., 2005). The momentary (right now) recall
timeframe does not measure frequency; therefore, a composite score could not be
created and instead, the right now timeframe served as a moderating variable in
the analysis of hypothesis II. There is currently no information on the test-retest
reliability of the CDC Symptom Inventory (Wagner et al., 2005) or on the
unpublished revised version (SI-R) altered by this author for the purposes of the
present study. The CFS Questionnaire, developed by Hawk et al. (2007) also
measures the Fukuda et al. (1994) case-defining symptoms using a six month
timeframe, and these items were found to have very good test-retest reliability,
with an average intraclass correlation score of .77 across all eight case-defining
symptoms (Hawke et al., 2007).
Symptom Stability
The Symptom Stability Survey (see Appendix B) was administered to
participants at both phone assessments and is a measure of the perceived stability
of each case defining symptom. For each symptom listed on the Symptom
Stability Survey, respondents indicated whether they perceived each symptom to
have been relatively stable, fluctuating/variable, or not present over the course of
the past six months. The Symptom Stability Survey was developed by this author
at DePaul University for the purposes of the current study and there is currently
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no information available on the internal consistency or test-retest reliability of this
measure. Future analyses will be conducted to obtain data on the psychometric
properties of the Symptom Stability Survey as well as the revised Symptom
Inventory (SI-R).
Demographic Information
Participants were administered a short demographic survey during the
first assessment and following completion of the SI-R and the Symptom Stability
Survey. The demographic survey included eight questions which assessed age,
gender, weight, height, race, marital status, occupational status, number of
children, and highest grade level.
Significant Events
At the end of each phone interview, participants were administered a
significant events questionnaire which asked questions related to the typicality of
participant mental and physical health over the week of the interview and whether
any recent significant events occurred that might have impacted mental and
physical health at the time of the interview. Responses to the significant events
questionnaire were not taken into account for the analyses presented in this paper,
but will be evaluated in future analyses of the presented study sample.
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CHAPTER III
RESULTS
The current study is an investigation of the effects of recall timeframe,
symptom stability, and momentary symptom severity on the reliability of
ME/CFS symptom reports. The present study utilized a multilevel modeling
(MLM) approach within a repeated measures design in order to assess the
reliability of symptom reports across two interview assessments. In order to assess
the reliability of symptom reports using an MLM approach, the slope coefficients
were observed, and those coefficients observed to be closest to 1.0, represented
more reliable symptom reporting. Additionally, MLM allows for the assessment
of nested data; thus providing a way to quantify the extent to which slope
coefficients vary as a function of symptom stability, changes in momentary (i.e.
right now) symptom severity, and timeframe. Presented below are the re-stated
hypotheses and research questions as well as subsequent MLM analyses and
results.
For hypothesis I, it was expected that ME/CFS symptom composite scores
would be recalled with greater consistency (yield stronger reliability coefficients)
across interview assessments, when symptoms were perceived as stable over time
rather than variable. A multilevel statistical model was used to test hypothesis I.
Level 1 of the model tested the extent that interview one symptom composite
scores predicted interview two symptom composite scores (see Table 1 for
descriptive information of all nine symptom composite scores across two waves
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and the three timeframes). Level 2 of the model tested whether the perceived
stability of each symptom (dummy coded as 1= stable and 0 = variable) :
(1) predicted the symptom composite scores at interview two, and (2) moderated
the reliability between interview one and interview two (see Table 2 for
descriptive information of the nine ME/CFS symptoms rated as variable; See
Table 3 for descriptive information of the nine ME/CFS symptoms rated as
stable). The symptom scores at the three recall timeframes were not analyzed
separately in the analysis but were grouped to represent a single variable referred
to as Interview One Scores Collapsed Across Timeframe. Group mean centering
was conducted for the Level 1 variables, so as to control for the influence of
between-person variance on the slope coefficients.

Level 1: y ij= b0 + b1 Interview One Scores Collapsed Across Timeframe ij + rij
Y= Symptom composite scores at all three timeframes, at interview two

Level 2: b0i= γ00 + γ01 Stability i + υi
b1i = γ10 + γ11 Stability i
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Table 1
Means and Standard Deviations of Symptom Composites on the SI-R at
Interviews 1 and 2, N=51
Symptom
Sore Throat

Lymph Nodes

Post Exertional
Malaise (PEM)
Muscle Pain

Joint Pain

Unrefreshing Sleep

Headaches

Memory Problems

Difficulty
Concentrating

Timeframe
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months
Week
Month
Six Months

Interview 1
M (SD)
4.25 (5.03)
4.24 (4.94)
5.35 (6.07)
5.71 (6.04)
5.53 (6.18)
6.43 (6.86)
16.82 (4.93)
17.00 (4.96)
17.90 (5.69)
12.00 (6.26)
11.73 (6.89)
12.18 (6.64)
8.94 (6.78)
9.45 (7.16)
9.63 (7.59)
16.92 (6.00)
16.25 (6.29)
16.20 (7.27)
7.39 (6.53)
7.37 (5.40)
8.41 (6.57)
10.47 (6.52)
10.47 (6.44)
10.90 (6.72)
11.75 (5.88)
11.86 (6.20)
12.71 (6.30)

Interview 2
M (SD)
4.88 (6.14)
4.10 (5.05)
5.21 (6.06)
5.14 (5.92)
4.76 (5.18)
5.45 (5.75)
16.86 (4.81)
16.53 (4.95)
17.14 (5.10)
11.00 (5.87)
11.33 (6.07)
11.35 (5.99)
9.35 (6.87)
8.90 (6.26)
9.24 (6.66)
17.41 (6.34)
15.82 (5.97)
15.94 (6.65)
7.25 (6.26)
6.76 (5.56)
7.41(5.37)
10.12 (7.14)
10.25 (6.66)
10.76 (6.89)
11.96 (6.75)
11.84 (6.25)
12.20 (6.39)
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Table 2
Means and Standard Deviations of Symptom Composites on the SI-R at
Interviews 1 and 2 for Symptoms Rated as Variable

Variable Symptoms
Sore Throats

Timeframe
Week
Month
Six months

Lymph Nodes
Week
Month
Six months
PEM
Week
Month
Six months
Muscle Pain
Week
Month
Six months
Joint Pain
Week
Month
Six months
Unrefreshing Sleep
Week
Month
Six months
Headache
Week
Month
Six months
Memory
Week
Month
Six months
Concentration
Week
Month
Six months

Interview 1

Interview 2

M (SD)
n=30
4.30 (4.20)
4.10 (3.43)
5.10 (4.20)
n=23
5.83 (4.56)
5.43 (4.83)
6.17 (4.52)
n=5
12.00 (2.12)
14.00 (6.36)
15.20 (7.79)
n=20
8.75 (4.66)
7.60 (4.92)
8.50 (4.76)
n=23
7.30 (5.45)
7.26 (5.15)
7.78 (5.66)
n=10
10.10 (5.92)
9.70 (4.72)
7.50 (4.79)
n=31
6.19 (5.21)
6.74 (5.11)
7.19 (5.94)
n=19
7.16 (5.27)
6.5 (5.2)
7.95 (6.51)
n=16
10.69 (5.92)
10.13 (5.71)
9.81 (4.07)

M (SD)
n=30
4.80 (5.01)
4.33 (4.44)
5.40 (5.75)
n=23
4.70 (4.26)
5.04 (4.83)
5.22 (3.43)
n=5
13.60 (5.55)
10.60 (3.71)
13.60 (3.05)
n=20
7.45(3.85)
7.85 (3.91)
7.75 (4.04)
n=23
7.26 (5.15)
7.61 (5.79)
7.22 (4.60)
n=10
11.30 (6.53)
10.00 (5.29)
7.70 (3.86)
n=31
6.68 (5.75)
5.65 (4.05)
6.45 (3.80)
n=19
7.63 (7.27)
7.32 (5.31)
7.37 (4.78)
n=16
10.06 (5.73)
9.81 (4.07)
10.75 (5.36)
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Table 3
Means and Standard Deviations of Symptom Composites on the
SI-R at Interviews 1 and 2 for Symptoms Rated as Stable

Stable Symptoms
Sore Throats

Timeframe
Week
Month
Six months

Lymph Nodes
Week
Month
Six months
PEM
Week
Month
Six months
Muscle Pain
Week
Month
Six months
Joint Pain
Week
Month
Six months
Sleep
Week
Month
Six months
Headache
Week
Month
Six months
Memory
Week
Month
Six months
Concentration
Week
Month
Six months

Interview 1

Interview 2

M (SD)
n=8
10.88 (5.00)
11.63 (5.45)
14.38 (7.01)
n=14
11.14 (6.24)
11.14 (6.41)
13.14 (7.43)
n=46
17.35 (4.87)
17.33 (4.76)
18.20 (5.45)
n=30
14.57 (5.86)
14.87 (6.27)
15.03 (6.20)
n=22
13.09 (5.89)
13.95 (6.03)
14.18 (7.20)
n=41
18.59 (4.76)
17.85 (5.58)
18.32 (6.12)
n=16
11.56 (7.20)
10.44 (4.41)
12.88 (5.49)
n=31
12.77 (6.28)
13.16 (5.75)
12.94 (6.21)
n=35
12.23 (5.88)
12.66 (6.32)
13.60 (6.57)

M (SD)
n=8
12.38 (7.73)
9.75 (5.83)
12.50 (4.41)
n=14
10.57 (6.72)
8.86 (6.01)
11.21 (6.42)
n=46
17.22 (4.65)
17.17 (4.65)
17.52 (5.15)
n=30
13.73(5.39)
14.03 (5.76)
14.10 (5.54)
n=22
13.72 (6.23)
12.91 (5.65)
13.73 (5.96)
n=41
18.90 (5.39)
17.24 (5.26)
17.95 (5.55)
n=16
9.94 (6.69)
10.50 (6.48)
11.00 (6.21)
n=31
11.94 (6.58)
12.35 (6.45)
13.13 (7.05)
n=35
12.83 (7.08)
12.77 (6.88)
13.17 (6.97)
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Hypothesis I was supported for three of the eight case-defining ME/CFS
symptoms: PEM, headaches, and memory problems. For post-exertional malaise,
there was a significant main effect of symptom stability F (1, 49) = 5.93, p = .019;
however, there was not a main effect of PEM composite scores at interview one,
F (1, 100) = .087, p = .768, in predicting PEM composite scores at interview two.
There was a significant interaction effect F(1, 100) = 4.16, p = .044, such that the
relationship between PEM composite scores at the first interview and PEM
composite scores at the second interview was significantly stronger for those who
rated their symptoms as stable than for those who did not, b = 0.48, SE = 0.23,
t(100) = 2.04, p = .044. The within variance of the distribution residuals was 6.98
and the between variance of distribution residuals was 14.50. The ICC score was
calculated as .68, suggesting that 68 percent of the variance in predicting PEM
scores at interview two is explained by the nesting of both individual factors and
symptom stability.
For headaches, there was a significant main effect of symptom stability
F(1, 45) = 9.62, p = .003, but not a main effect of memory composite scores at
interview one F(1, 92) = 0.01, p = .931, in predicting headache composite scores
at interview two. There was a significant interaction effect
F(1, 92) =13.74, p < .001, such that the relationship between headache composite
scores at interview one and headache composite scores at interview two was
significantly stronger for those who rated their symptoms as stable than for those
who did not, b = 0.66, SE = 0.18, t(92) = 3.71, p < .001. The within variance of
the distribution residuals was 9.90 and the between variance of distribution
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residuals was 16.24. The ICC score was calculated as .45, suggesting that 45
percent of the variance in predicting headache scores at interview two is explained
by the nesting of both individual factors and symptom stability.
For memory problems, there was a significant main effect of symptom
stability F(1, 48) = 7.94, p = .008, but not a main effect of memory composite
scores at interview one F(1, 98) = 0.91, p = .343, in predicting memory composite
scores at interview two. There was a significant interaction effect F(1, 98) = 9.45
p = .003, such that the relationship between memory composite scores at
interview one and memory composite scores at interview two was significantly
stronger for those who rated their symptoms as stable than for those who did not,
b = 0.53, SE = 0.17, t(98) = 3.07, p = .003. The within variance of the distribution
residuals was 5.32 and the between variance of distribution residuals was 35.84.
The ICC score was calculated as .87, suggesting that 87 percent of the variance in
predicting headache scores at interview two is explained by the nesting of
individual factors and symptom stability.
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For Hypothesis II, it was expected that an increase in momentary (right
now) symptom severity ratings from interview one to interview two would
significantly predict an increase in past week, past month, and past six month
symptom scores from interview one to interview two. A decrease in momentary
(right now) symptom severity ratings from interview one to interview two will
significantly predict a decrease in past week, past month, and past six month
symptom scores from interview one to interview two (for a display of the means
and standard deviations of the symptom severity scores at all four timeframes and
across interviews one and two, please refer to Table 7 under Appendix C).
A multilevel statistical model was used to test Hypothesis II. Level 1 of
the model tested the extent that past week, past month, and past six month
symptom composite scores (variable notation in the model is Timeframe)
predicted symptom composite scores at interview two. Level 2 of the model tested
whether the change (increase or decrease) in Right Now severity ratings over a
one week interval predicted symptom composite scores (i.e. collapsed across
timeframe) at interview two. In order to determine the change in momentary
severity at each symptom from interview one to interview two, a Right now
Difference Score (Right Now Diff.) was calculated (Right Now severity score at
interview two minus Right Now severity score at Interview one). The model
presented below was re-estimated changing the reference group for timeframe, in
order to test the significance of the slope for each timeframe. Timeframe is a
categorical variable that is dummy coded in the estimation of the model. Two
dummy vectors are used for each time that Timeframe appears in the model.
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Level 1: y ij = b0 + b1 Timeframe ij + rij
y= Symptom composite scores at interview two

Level 2: b0i= γ00 + γ01 Right Now Diff. i
b1i= γ10 + γ11 Right now Diff. i
Hypothesis II was supported for two of the case-defining ME/CFS symptoms,
sore throats and difficulty concentrating, but only when the reference group was
six months.
Sore Throat
The right now difference score significantly predicted sore throat scores
at interview two, when the reference group was the six month timeframe, b =
4.21, SE = 1.86, t(22.09) = 2.26, p =.03, such that, an increase in the right now
severity score from interview one to interview two, significantly predicted an
increase in the sore throat composite score for interview two. The right now
difference score does not significantly predict sore throat composite scores at
interview two, when the reference group is the past month timeframe, the b =
1.38, SE = 1.86, t(22.09) = 0.74, p = .466. The right now difference score did not
significantly predict sore throat composite scores at interview two, when the
reference group is the past week timeframe, the b = 2.15, SE = 1.86, t(22.09) =
1.15, p = .262. There was no difference in the relationship between the right now
difference score and the outcome based on the timeframes; the relationship
between past week did not differ from past six months (b = -2.07, SE = 1.63, t(26)
= -1.27, p = .22) and the relationship between past month did not differ from past
six months (b = -2.83, SE = 1.63, t(26) = -1.74, p = .09). The within variance of
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the distribution residuals was 14.50 and the between variance of distribution
residuals was 23.52. The ICC score was calculated as .58, suggesting that 58
percent of the variance in predicting sore throat scores at interview two was
explained by the nesting of individual factors and the right now difference score.
Concentration
The right now difference score significantly predicted concentration
composite scores at interview two, when the reference group was the six month
timeframe, b = 2.11, SE = 0.93, t(56.40) = 2.27, p = .03. The right now difference
score only marginally predicted concentration composite scores at time two, when
the reference group was the past month, b = 1.68, SE = 0.93, t(56.40) = 1.80, p =
.078. The right now difference score did not significantly predict concentration
scores at time two, when the reference group was the past month timeframe, b =
1.35, SE = 0.93, t(56.40) = 1.45, p =.153. There was no difference in the
relationship between the concentration difference score and the outcome scores
based on the timeframes; past week did not differ from past six months (b = 1.68,
SE = 0.59, t(86) = -0.746, p = .46) and past month does not differ from past six
months, b = 1.35, SE = 0.59, t(86) = -1.30, p = .196. The within variance of the
distribution residuals was 7.49 and the between variance of distribution residuals
was 30.40. The ICC score was calculated as .80, suggesting that 80 percent of the
variance in predicting sore throat scores at interview two is explained by the
nesting of individual factors and the right now difference score.
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For research question Ia, it was asked, what is the optimal recall timeframe
in terms of test-retest reliability, for ME/CFS symptoms that are perceived as
variable/unstable over time? Research question Ib was supplementary to Ia and
reads, what is the optimal recall timeframe in terms of test-retest reliability, for
ME/CFS symptoms that are perceived as stable over time?
A multilevel model was used in the analysis of research question Ia and Ib.
In the model presented below, the outcome variable represents the symptom
composite scores reported at interview two. For ease of description, level 2 of the
model tested (1) the extent that symptom composite scores at interview one
predicted composite scores at interview two, and (2) how timeframe moderated
the way symptom composites at interview one predicted scores at interview two.
Level 1 of the model tested the main effect of timeframe. Analyses for research
question Ia and Ib were both conducted using the formula listed below selecting
out for variable and stable symptoms. Grand mean centering was conducted for
the Level 2 variables, so as to ease interpretation.

Level 1: yij= b0i + b1i Past Week Vs Six Months ij + b2i Past Month Vs
Six Months ij + rij
Level 2: b0i= γ00 + γ01 Symptom Score at Interview One i+ ri
b1i= γ10 + γ11 Symptom Score at Interview One i
b2i= γ20 + γ21 Symptom Score at Interview One i
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Variable Sore Throats
When sore throats were rated as variable, sore throat composite scores at
interview one significantly predicted sore throat composite scores at interview
two, for the six month reference, b = 0.80, SE = 0.17, t(62.39) = 4.81, p < .001.
The relationship between interview one and interview two is significantly stronger
for the six month timeframe compared to the past week (b = 0.20, SE = 0.28,
t(65.03) = -2.1, p = .04) and the past month (b = -0.04, SE = -0.84, t(60.62) = 2.28, p=.026). The slope coefficient for the six month reference was closest to 1.0
at .80, suggesting that six months is the optimal timeframe for variable sore
throats. The within variance of the distribution residuals was 3.83 and the between
variance of distribution residuals was 21.26. The ICC score was calculated as .85,
suggesting that 85 percent of the variance in predicting variable sore throat scores
at interview two is explained by the nesting of both individual factors and the sore
throat scores at interview one.
Stable Sore Throats
Sore throat scores at interview one did not significantly predict sore throat
scores at interview two, when the reference was the past six months, b = 0.18, SE
= 0.76, t(16.67) = 0.23, p = .819, the past month, b = 1.84, SE = 1.34, t(15.13)
= 1.38, p = .188, or the past week, b = -0.97, SE = 0.85, t(16.25) = -1.15, p = .268.
There is no difference in the relationship between the sore throat scores at
interview one and interview two based on the timeframes; the relationship
between past six months does not differ from the past month (b = 1.84, SE = 1.63,
t(16.73) = 1.02, p = .322) or from the past week (b = -0.97, SE = 1.29, t(17.85) = -
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0.90, p = .380). The slope coefficient for the six month reference was closest to
1.0 at 0.18, suggesting that six months is the optimal timeframe for variable sore
throats. Although six months was determined as optimal, all three timeframes
produced slope coefficients with poor predictive validity relative to the other
symptoms, suggesting that within the study population, there is poor reliability in
reporting sore throats that are experienced as stable. The within variance of the
distribution residuals was 19.76 and the between variance of distribution residuals
was 17.01. The ICC score was calculated as .46, suggesting that 46 percent of the
variance in predicting stable sore throat scores at interview two is explained by
the nesting of individual factors and sore throat scores at interview one.
Variable Lymph Node Pain.
When lymph node pain was rated as variable over time, lymph node
scores at interview one significantly predicted lymph node scores at interview two
for the six month reference, b = 0.77, SE = 0.28, t(47.43) = 2.71, p = .009.
Interview one did not significantly predict lymph node scores at interview two for
the past month reference, b = 0.07, SE = 0.33, t(46.08) = 0.22, p = .824, or the
past week interval, b = 0.03, SE = 0.29, t(47.25) = 0.12, p = .91. There is no
difference in the relationship between the lymph node scores at interview one and
interview two based on the timeframes; the relationship between past six months
does not differ from the past month (b = 0.07, SE = 0.47, t(47.90) = -1.48, p =
.145) or from the past week (b = 0.03, SE = 0.45, t(49.67) = -1.619, p = .112). The
six month slope coefficient was closest to 1.0 at .77, suggesting that six months is
the optimal timeframe for lymph node pain experienced as variable. The within

37

variance of the distribution residuals was 3.44 and the between variance of
distribution residuals was 11.52. The ICC score was calculated as .77, suggesting
that 77 percent of the variance in predicting variable sore lymph node scores at
interview two is explained by the nesting of individual factors and sore throat
scores at interview one.
Stable Lymph Node Pain
When lymph node pain was rated as stable over time, lymph node scores
at interview one significantly predicted lymph node scores at interview two, for
the six month reference, b = 1.30, SE = 0.49, t(28.53) = 2.63, p = .014. Lymph
node scores at interview one did not significantly predict scores at interview two
for the past month, b = 0.30, SE = 0.86, t(26.62) = 0.35, p = .731, or the past
week, b = 0.12, SE = 0.60, t(29.83) = 1.29, p = .847. There is no difference in the
relationship between the lymph node scores at interview one and interview two
based on the timeframes; the relationship between past six months does not differ
from the past month (b = 0.30, SE = 1.12, t(28.70) = -0.89, p = .380) or from the
past week, b = 0.12, SE = 0.92, t(29.83) = -1.29, p = .207. The six month slope
coefficient was closest to 1.0 at 1.30, suggesting that six months is the optimal
timeframe for lymph node pain experienced as stable. The within variance of the
distribution residuals was 7.86 and the between variance of distribution residuals
was 31.44. The ICC score was calculated as .80, suggesting that 80 percent of the
variance in predicting stable lymph node scores at interview two is explained the
nesting of individual factors and stable lymph node scores at interview one.
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Variable Post-Exertional Malaise
When PEM was rated as variable, PEM scores at interview one did not
significantly predict PEM scores at interview two, for the past six month
reference, b = 0.31, SE = 0.45, t(6.93) = 0.68, p = .518, the past month, b = 0.44,
SE = 0.63, t(6.35) = 0.71, p = .505, or the past week, b = -0.29, SE = 0.47,
t(6.84) = -.62, p = .557. There was no difference in the relationship between PEM
scores at interview one and at interview two based on the timeframes; the
relationship between six months did not differ from past month (b = 0.44, SE =
0.82, t(6.94) = 0.16, p = .875) or from the past week (b = -0.29, SE = 0.73, t(7.72)
= -0.82 p = .438). The slope coefficient for the past month reference is closest to
1.0 at .44, suggesting that the past month timeframe is optimal for PEM that is
experienced as variable. All three timeframes produced slope coefficients with
poor predictive validity relative to the other variable symptoms, suggesting that
within this study population, there is poor reliability in reporting PEM that is
experienced as variable. The within variance of the distribution residuals was 7.23
and the between variance of distribution residuals was 9.66. The ICC score was
calculated as .57, suggesting that 57 percent of the variance in predicting variable
PEM scores at interview two is explained by the nesting of individual factors and
variable PEM scores at interview one.
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Stable Post-Exertional Malaise
When PEM scores were rated as stable over time, PEM scores at
interview one significantly predicted PEM scores at interview two for the six
month reference, b = 0.79, SE = 0.19, t(106.85) = 4.09, p < .001 and at the past
week reference, b = 0.44, SE = 0.21, t(104.93) = 2.13, p = .04. There was no
difference in the relationship between PEM scores at interview one and at
interview two based on the timeframes; the relationship between six months does
not differ from past month, b = 0.30, SE= 0.33, t(109.37) = -1.5, p = .142, or from
the past week, b = 0.44, SE = 0.32, t(112.91) = -1.09, p = .275. The slope
coefficient for the six month reference is closest to 1.0 at .79, suggesting that the
six month timeframe is optimal for reporting PEM experienced as stable. The
within variance of the distribution residuals was 7.01 and the between variance of
distribution residuals was 14.82. The ICC score was calculated as .68, suggesting
that 68 percent of the variance in predicting stable PEM scores at interview two is
explained the nesting of individual factors and stable PEM scores at interview
one.
Variable Muscle Pain
When muscle pain was rated as variable over time, muscle pain scores at
interview one significantly predicted muscle pain scores at interview two for the
six month reference, b = 0.56, SE = 0.25, t(40.21) = 2.25, p = .03. Interview one
did not significantly predict muscle pain scores at interview two for the past
month reference, b = -0.22, SE = 0.36, t(38.12) = -0.60, p = .553, or the past week
b = -0.23, SE = 0.24, t(40.54) = -0.98, p = .335. The relationship between
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interview one and interview two for the six month timeframe is marginally
stronger compared to the past week, b = -0.23, SE = 0.40, t(42.70) = -1.99, p =
.054, and the past month b = -0.22, SE = .45, t(38.79) = -1.73, p = .09. The slope
coefficient at the past six month interval is closest to 1.0 at .56, suggesting that the
past six month timeframe is optimal for reporting muscle pain experienced as
variable. The within variance of the distribution residuals was 3.28 and the
between variance of distribution residuals was 12.65. The ICC score was
calculated as .79, suggesting that 79 percent of the variance in predicting variable
muscle pain scores at interview two is explained the nesting of individual factors
and variable muscle pain scores at interview one.
Stable Muscle Pain
When muscle pain scores were rated as stable over time, muscle pain
scores at interview one marginally predicted scores at interview two for the six
month reference, b = 0.82, SE = 0.44, t(72.40) = 1.86, p = .067. Interview one
scores did not predict interview two scores for the past month, b = 0.75, SE =
0.55, t(69.15) = 1.35, p = .182, or the past week, b = -0.23, SE = 0.24, t(40.54) = .98, p = .335. The relationship between interview one and interview two was
significantly stronger at the six month reference compared to the past week (b = 0.56, SE = 0.66, t(79.89) = -2.08, p = .041). The relationship between interview
one and interview two for the past six months was no different than the past
month (b = 0.75, SE = 0.72, t(69.93) = -1.02, p = .919). The slope coefficient at
the six month interval is closest to 1.0 at .82, suggesting that the past six month
timeframe is optimal for reporting muscle pain experienced as stable. The within
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variance of the distribution residuals was 13.75 and the between variance of
distribution residuals was 16.70. The ICC score was calculated as .55, suggesting
that 55 percent of the variance in predicting stable muscle pain scores at interview
two is explained by the nesting of individual factors and stable muscle pain scores
at interview one.
Variable Joint Pain
When joint pain was rated as variable, scores at interview one marginally
predicted scores at interview two, for the past week reference, b = 0.58, SE =
0.29, t(47.81) = 2.00, p = .051. Interview one does not significantly predict joint
pain scores at interview two, for the past month, b = 0.15, SE = 0.33, t(47.35) =
0.45, p = .655, or the past six months, b = 0.22, SE = 0.21, t(49.54) = 1.04, p =
.304. There is no difference in the relationship between joint pain scores at
interview one and at interview two based on the timeframes; the relationship
between past week does not differ from past month (b = 0.15, SE = 0.38, t(42.77)
= 1.14, p = .260) or from the past six months, (b = 0.22, SE = 0.43, t(51.05) =
0.85, p=.399). The slope coefficient for the past week is closest to 1.0 at .58,
suggesting that the past week timeframe is optimal for reporting joint pain
experienced as variable. The within variance of the distribution residuals was 3.29
and the between variance of distribution residuals was 19.35. The ICC score was
calculated as .85, suggesting that 85 percent of the variance in predicting variable
joint pain scores at interview two is explained by variable joint pain scores at
interview one.
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Stable Joint Pain
When joint pain was rated as stable over time, joint pain scores at
interview one significantly predicted joint pain scores at interview two for the six
month reference, b = 0.95, SE = 0.35, t(46.75) = 2.72, p = .009, and the past
month reference, b = 1.82, SE = .53, t(43.62) = 3.43, p=.001. Interview one scores
did not significantly predict interview two scores for the past week, b = -0.64, SE
= 0.37, t(46.25) = -1.74, p = .089. The relationship between joint pain scores at
interview one and interview two was significantly different by timeframe; the
relationship at the past six months was significantly stronger compared to the past
week (b = -0.64, SE = 0.58, t(49.57) = -2.72, p = .009) but not significantly
stronger than the past month (b = 1.82, SE = 0.68, t(45.98) = 1.28, p = .206). The
slope coefficient for the past six month interval is closest to 1.0 at .95, suggesting
that the past six month timeframe is optimal for reporting joint pain experienced
as stable. The within variance of the distribution residuals was 8.48 and the
between variance of distribution residuals was 25.99. The ICC score was
calculated as .75, suggesting that 75 percent of the variance in predicting stable
joint pain scores at interview two is explained by the nesting of individual factors
and stable joint pain scores at interview one.
Variable Unrefreshing Sleep
When unrefreshing sleep was rated as variable, unrefreshing sleep scores
at interview one did not significantly predict scores at interview two for the past
six month timeframe, b = 0.30, SE = 0.56, t(17.71) = 0.54, p = .598, the past
month, b = 0.82, SE = 0.67, t(17.22) = 1.22, p = .238, or the past week
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timeframe, b = 0.64, SE = 0.48, t(18.35) = 1.33, p = .199. There was no difference
in the relationship between unrefreshing sleep scores at interview one and at
interview two based on the timeframes; the relationship between interview one
and two at the past month timeframe does not differ from past six months (b =
0.30, SE = 0.86, t(16.82) = 0.60, p = .557) or from the past week (b = 0.64, SE =
0.91, t(18.64) = -.20 p = .844). The slope coefficient at the past month reference is
closest to 1.0 at .82, suggesting that the past month timeframe is optimal for
reporting unrefreshing sleep experienced as variable. The within variance of the
distribution residuals was 6.90 and the between variance of distribution residuals
was 20.81. The ICC score was calculated as .75, suggesting that 75 percent of the
variance in predicting variable unrefreshing sleep scores at interview two is
explained by the nesting of individual factors and unrefreshing sleep scores at
interview one.
Stable Unrefreshing Sleep
When unrefreshing sleep was rated as stable, unrefreshing sleep scores at
interview one significantly predicted unrefreshing sleep scores at interview two
when the interval was six months, b = 0.41, SE = 0.17, t(95.17) = 2.34, p = .021.
Unrefreshing sleep at interview one did not significantly predict unrefreshing
sleep at interview two, for the past month reference, b = 0.29, SE = 0.23, t(91.14)
= 1.24, p = .218 or the past week, b = 0.18, SE = 0.26, t(89.80) = 0.67, p = .504.
There was no difference in the relationship between unrefreshing sleep scores at
interview one and at interview two based on the timeframes; the relationship
between interview one and two at the six month timeframe does not differ from
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past month (b = 0.29, SE = 0.34, t(98.72) = -0.37, p = .713) or from the past week
(b = 0.18, SE = 0.36, t(97.29) = -0.64, p = .525). The slope coefficient at the six
month reference was closest to 1.0 at .41, suggesting that the six month timeframe
is optimal for reporting unrefreshing sleep experienced as stable. The within
variance of the distribution residuals was 5.90 and the between variance of
distribution residuals was 22.79. The ICC score was calculated as .79, suggesting
that 79 percent of the variance in predicting stable unrefreshing sleep scores at
interview two is explained by the nesting of individual factors and stable
unrefreshing sleep scores at interview one.
Variable Headaches
Headache scores at interview one did not significantly predict headache
scores at interview two, for the six month reference, b = 0.32, SE = 0.24, t(74.54)
= 1.30, p = .197, the past month, b = -0.51, SE = 0.36, t(69,80) = -1.42, p = .159,
or the past week reference, b = -0.08, SE = 0.22, t(76.77) = -.37, p = .711. The
relationship between headaches at interview one and two at the past six months
was marginally different from the past month (b = -0.51, SE = 0.43, t(68.40) = 1.93, p = .058) but was not significantly different from the past week (b = -0.08,
SE = 0.37, t(82.31) = -1.07, p = .289). The slope coefficient at the past six month
reference is closest to 1.0 at .32, suggesting that the six month timeframe is
optimal for reporting headaches experienced as variable. The within variance of
the distribution residuals was 8.21 and the between variance of distribution
residuals was 12.50. The ICC score was calculated as .60, suggesting that 60
percent of the variance in predicting variable headache scores at interview two is
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explained by the nesting of individual factors with variable headache scores at
interview one.
Stable Headaches
When headaches were rated as stable over time, headache scores at
interview one significantly predicted headache scores at interview two, when the
reference was six months, b = 1.40, SE = 0.23, t(30.36) = 6.04, p < .001.
Headache scores at interview one did not significantly predict headache scores at
interview two at the past month, b = 0.30, SE = 0.48, t(27.75) = 0.62, p = .543, or
the past week, b = 0.00, SE = 0.24, t(30.17) = 0.01, p = .991. The relationship
between Headache scores at interview one and headache scores at interview two
was significantly stronger at the past six month reference compared to the past
week

(b = 0.00, SE = 0.39, t(32.27) = -3.55, p = .001) and marginally stronger

than the past month (b = 0.30, SE = 0.56, t(28.85)= -1.98, p = 0.058). The slope
coefficient at the past six month reference is closest to 1.0 at 1.40, suggesting that
the six month timeframe is optimal for reporting headaches that are stable. The
within variance of the distribution residuals was 8.63 and the between variance of
distribution residuals was 36.75. The ICC score was calculated as .81, suggesting
that 81 percent of the variance in predicting variable headache scores at interview
two is explained by the nesting of individual factors and headache scores at
interview one.
Variable Memory Problems
Memory scores at interview one did not significantly predict Memory
scores at interview two for the six month reference, b = -0.14, SE = 0.29, t(39.71)
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= -0.50, p = .618, the past month, b = -0.07, SE = 0.45, t(37.23) = -0.15, p =
.881, or the past week interval, b = -0.14, SE = 0.34, t(38.47) = -.41, p = .688.
There was no difference in the relationship between memory scores at interview
one and at interview two based on the timeframes; the past six months was not
significantly different from the past month, b = -0.07, SE = 0.59, t(40.01) = 0.13,
p = .898 or from the past week, b = -0.14, SE = 0.52, t(41.43) = 0.01, p = .991.
The slope coefficient for the past month reference is closest to 1.0 at -.07,
suggesting that the six month timeframe is optimal for reporting variable memory
problems. Although the past month reference was determined as optimal, all
three timeframes produced slope coefficients with poor predictive validity,
suggesting that within this study population, there is poor reliability in reporting
memory problems that are experienced as variable. The within variance of the
distribution residuals was 7.22 and the between variance of distribution residuals
was 28.07. The ICC score was calculated as .80, suggesting that 80 percent of the
variance in predicting variable memory scores at interview two is explained by
the nesting of individual factors and memory scores at interview one.
Stable Memory Problems
When memory problems were rated as stable over time, memory scores at
interview one significantly predicted memory scores at interview two, when the
reference was six months, b = 1.03, SE = 0.19, t(60.72) = 5.32, p < .001. Memory
scores at interview one did not significantly predict memory scores at interview
two at the past month, b = 0.04, SE = 0.29, t(59.13) = .14, p = .893, or the past
week, b = -0.17, SE = 0.21, t(60.32) = -8.26, p = .412. The relationship between
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memory scores at interview one and memory scores at interview two was
significantly stronger at the past six months compared to the past week (b = -0.17,
SE = 0.33, t(61.88) = -3.61, p = 0.001) and the past month (b = 0.04, SE = 0.38,
t(60.42) = -2.63, p = .011). The slope coefficient at the past six month interval is
closest to 1.0 at 1.03, suggesting that the six month timeframe is optimal for
reporting memory problems experienced as stable. The within variance of the
distribution residuals was 3.62 and the between variance of distribution residuals
was 41.44. The ICC score was calculated as .92, suggesting that 92 percent of the
variance in predicting stable memory scores at interview two is explained by
stable memory scores at interview one.
Variable Concentration Problems
When concentration scores were experienced as variable, concentration
scores at interview one did not significantly predict concentration scores at
interview two for the six month reference, b = 0.20, SE = 0.43, t(35.81) = 0.46, p
= .647, the past month, b = -0.17, SE = 0.37, t(36.39) = -0.45, p = .654, or the
past week reference, b = 0.04, SE = 0.27, t(39.80) = 0.27, p = .786. There was no
difference in the relationship between concentration scores at interview one and at
interview two based on the timeframes; the past six months was not significantly
different from the past month (b = -0.17, SE = 0.51, t(29.98) = -0.73, p = .473) or
the past week (b = 0.04, SE = 0.58, t(39.80) = -0.27, p = .786). The slope
coefficient at the six month reference is closest to 1.0 at .20, suggesting that the
six month timeframe is optimal for reporting variable concentration problems.
Although the six month interval was determined as optimal, all three timeframes
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produced slope coefficients with poor predictive validity, suggesting that within
the current population, there is poor reliability in reporting concentration
problems that are experienced as variable. The within variance of the distribution
residuals was 8.00 and the between variance of distribution residuals was 15.87.
The ICC score was calculated as .66, suggesting that 66 percent of the variance in
predicting variable concentration scores at interview two is explained by the
nesting of individual factors and concentration scores at interview one.
Stable Concentration Problems
When concentration problems were rated as stable over time,
concentration scores at interview one significantly predicted concentration scores
at interview two, when the reference was six months, b = 0.47, SE = 0.23, t(74.15)
= 2.07, p = .042. Concentration scores at interview one did not significantly
predict concentration scores at interview two for the past month reference, b =
0.14, SE = 0.30, t(71.73) = 0.48, p = .634, or the past week, b = -0.43, SE = 0.31,
t(71.52) = -1.41, p = .164. The relationship between concentration scores at
interview one and concentration scores at interview two was significantly stronger
at the past six month interval compared to the past week (b = -0.43, SE = 0.44,
t(75.46) = -2.05, p = .044) and the past month (b = 0.14, SE = 0.43, t(75.68) = 0.76, p = .451). The slope coefficient for the six month reference is closest to 1.0
at .47, suggesting that the six month timeframe is optimal for reporting stable
concentration problems. The within variance of the distribution residuals was
19.76 and the between variance of distribution residuals was 17.00. The ICC
score was calculated as .46, suggesting that 46 percent of the variance in

49

predicting stable concentration scores at interview two is explained by the nesting
of individual factors and stable concentration scores at interview one (see Table 4
for slope coefficients of variable ME/CFS symptoms at all three timeframes; see
Table 5 for slope coefficients of stable ME/CFS symptoms at all three
timeframes).
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Table 4
Slope Coefficients of Variable ME/CFS symptoms at Three Timeframes
Variable Symptoms
Sore Throat

Lymph Node Pain

PEM

Muscle Pain

Joint Pain

Unrefreshing Sleep

Headaches

Memory

Concentration

Timeframe
Week
Month

b
0.20
-0.04

SE
0.17
0.31

df
61.99
58.68

t
1.19
-.14

p
.239
.888

Six Months*

0.80

0.17

62.39

4.81

<.001

Week

0.03

0.29

47.25

0.12

.91

Month

0.07

0.33

46.08

0.22

.824

Six Months*

0.77

0.28

47.43

2.71

.009

Week

-0.29

0.47

6.84

-0.62

.557

Month*

0.44

0.63

6.35

0.706

.505

Six Months

0.31

0.45

6.93

0.68

.518

Week

-0.23

0.24

40.54

-0.98

.335

Month

-0.22

0.36

38.12

-0.60

.553

Six Months*

0.56

0.25

40.21

2.25

.03

Week*

0.58

0.29

47.81

2.00

.051

Month

0.15

0.33

47.35

0.45

.655

Six Months

0.22

0.21

49.54

1.04

.304

Week

0.64

0.48

18.35

1.33

.199

Month*

0.82

0.67

17.22

1.22

.238

Six Months

0.30

0.56

17.71

0.54

.598

Week

-0.08

0.22

76.77

-0.37

.711

Month

-0.51

0.36

69.80

-1.42

.159

Six Months*

0.32

0.24

74.54

1.30

.197

Week

-0.14

0.34

38.47

-0.41

.688

Month*

-0.07

0.45

37.23

-0.15

.881

Six Months

-0.14

0.29

39.71

-0.50

.62

Week

0.04

0.27

39.80

0.27

.786

Month

-0.17

0.37

36.39

-0.45

.654

Six Months*

0.20

0.43

35.81

0.46

.647

Note. The symbol * refers to the optimal timeframe (coefficients closest to 1.0)
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Table 5
Slope Coefficients of Stable ME/CFS symptoms at Three Timeframes
Stable Symptoms
Sore Throat

Lymph Node Pain

PEM

Muscle Pain

Joint Pain

Unrefreshing Sleep

Headaches

Memory

Concentration

Timeframe
Week
Month

b
-0.97
1.84

SE
0.85
1.34

df
16.25
15.13

t
-1.15
1.38

p
.268
.188

Six Months*

0.18

0.76

16.67

0.23

.819

Week

0.12

0.60

29.83

1.29

.847

Month

0.30

0.86

26.62

.347

.731

Six Months*

1.30

0.49

28.53

2.63

.014

Week

0.44

0.21

104.93

2.13

.04

Month

0.30

0.23

102.45

1.31

.195

Six Months*

0.79

0.19

106.85

4.09

<.001

Week

-0.56

0.40

74.44

-1.41

.164

Month

0.75

0.55

69.15

1.35

.182

Six Months*

0.82

0.44

72.40

1.86

.067

Week

-0.64

0.37

46.25

-1.74

.089

Month

1.82

0.53

43.62

3.43

.001

Six Months*

0.95

0.35

46.75

2.72

.009

Week

0.18

0.26

89.80

0.67

.504

Month

0.29

0.23

91.14

1.24

.218

Six Months*

0.41

0.17

95.17

2.34

.021

Week

0.00

0.24

30.17

0.012

.991

Month

0.30

0.48

27.75

0.62

.543

Six Months*

1.40

0.23

30.36

6.04

<.001

Week

-0.17

0.21

60.32

-8.26

.412

Month

0.04

0.29

59.13

0.14

.893

Six Months*

1.03

0.19

60.72

5.32

<.001

Week

-0.43

0.31

71.52

-1.41

.164

Month

0.14

0.30

71.73

.48

.634

Six Months*

0.47

0.23

74.15

2.07

.042

Note. The symbol * refers to the optimal timeframe (coefficients closest to 1.0)
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For research question II it was asked, does the optimal recall timeframe in
terms of test-retest reliability, differ significantly by the ME/CFS symptom
measured? A multilevel statistical model was used to test Research question II.
Level 1 of the model tested (1) the main effect of timeframe, (2) the extent that
symptom composite scores at interview one predicted composite scores at
interview two, (3) the interaction of timeframe and symptom composite scores at
interview one in predicting scores at interview two, and (4) how symptom type
moderated the way symptom composite scores at interview one predicted
composite scores at interview two. Level 2 of the model tested the main effect of
symptom type. The variable Symptom Type included in the model below,
represents all nine ME/CFS symptoms, each with a designated code (e.g. Sore
throat = 1, Lymph Node = 2…etc). Group mean centering was conducted for the
Level 1 continuous variables, so as to control for the influence of between-person
variance on the slope coefficients.
Level 1: yij= b0i + b1 Timeframe + b2 Symptom Composite Score at Interview One
+ b3 Timeframe (Symptom Composite Score at Interview One) + rij
y= Symptom Score at Interview Two

Level 2: b0i = γ00 + γ01 Symptom Type + υij
b1i= γ10 + γ11 Symptom Type
b2i= γ20 + γ21 Symptom Type
b3i= γ30 + γ31 Symptom Type
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The omnibus F test revealed that symptom scores at interview one
significantly predicted symptom scores at interview two, F(1, 1273.30) =
1435.34, p < .001. There was a significant main effect of symptom type (F(8,
1275.66) = 11.17, p < .001) but not a significant main effect of timeframe, (F(2,
1273.88) = 1.97, p = .139). There were no significant two-way interactions, such
that timeframe by interview one scores (F(2, 1275.92) = 1.79, p =.168), symptom
type by interview one scores (F(8, 1282.22) = 1.71, p =.091), and timeframe by
symptom type, (F(16, 1273.32) = 0.36, p = .990) were all insignificant.
Additionally, There was not a significant three way interaction between
timeframe, symptom type, and interview one symptom scores, F(16, 1273.67) =
0.343, p = .993; hence, the optimal recall timeframe does not differ by the
ME/CFS symptom being measured.
Research question III is supplemental, and speculates, what the optimal
recall timeframe is in terms of test-retest reliability, in the absence of contextual
factors (e.g. stability and momentary symptom severity scores)? For ease of
description, level 2 of the model tested (1) the extent that symptom composite
scores at interview one predicted composite scores at interview two, and (2) how
timeframe moderated the way symptom composite scores at interview one
predicted scores at interview two. Level 1 of the model tested the main effect of
timeframe. Analyses for research question III were conducted using all ME/CFS
symptom scores regardless of stability ratings. Grand mean centering was
conducted for the Level 2 variables, so as to ease interpretation.
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Level 1: yij= b0 + b1Past Week Vs Six Months ij + b2 Past Month Vs
Six Months ij + rij
y= Symptom Score at Interview Two

Level 2: b0i= γ00 + γ01 Symptom Score at Interview One i + υij
b1i= γ10+ γ11 Symptom Score at Interview One i
b2i= γ20 + γ21 Symptom Score at Interview One i

Results of the above analyses revealed that the slope coefficients for all
but one symptom (e.g. all except joint pain) were optimal at the six month
timeframe in reliably reporting ME/CFS symptoms, in the absence of contextual
level two factors (stability and momentary severity). The slope coefficient for
joint pain scores reveal that the past month is optimal for reliably reporting joint
pain (Please see Table 6 for slope coefficients of ME/CFS symptoms rated at all
three timeframes without contextual factors).
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Table 6
Slope Coefficients of ME/CFS symptoms across timeframe Sans Stability
All Symptoms
Sore Throat

Lymph Node Pain

PEM

Muscle Pain

Joint Pain

Unrefreshing Sleep

Headaches

Memory

Concentration

Timeframe
Week
Month

b
-0.06
0.33

SE
0.19
0.33

df
11.40
105.04

t
-0.30
1.01

p
.763
.316

Six Month*

0.75

0.18

112.63

4.25

<.001

Week

-.10

0.24

105.42

-0.42

.678

Month

.12

0.30

103.33

0.39

.698

Six Month*

1.15

0.22

106.95

5.28

<.001

Week

0.30

0.19

116.47

1.57

1.20

Month

0.28

0.22

112.99

1.29

.201

Six Month*

0.72

0.18

118.12

3.98

<.001

Week

-0.48

0.25

117.12

-1.87

.064

Month

0.43

0.36

109.84

1.19

.236

Six Month*

0.74

0.28

114.81

2.68

.009

Week

-0.09

0.25

108.39

-.358

.721

Month*

0.81

0.32

105.77

2.53

.013

Six Month

0.54

0.21

111.03

2.60

.010

Week

0.29

0.23

107.74

1.27

.207

Month

0.35

0.21

108.34

1.63

1.63

Six Month*

0.47

0.16

112.28

2.84

.005

Week

-0.01

0.16

118.48

-0.09

.932

Month

-0.33

0.28

108.24

-1.18

.240

Six Month*

0.92

0.17

117.52

5.43

<.001

Week

-0.09

0.20

105.52

-0.45

.656

Month

0.02

0.26

103.15

0.09

.933

Six Month*

0.38

0.17

107.16

2.20

.03

Week

-0.18

0.19

107.62

-0.96

.338

Month

0.06

0.22

105.14

0.29

.770

Six Month*

0.42

0.19

107.33

2.24

.027

Note. The symbol * refers to the optimal timeframe (coefficients closest to 1.0)
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CHAPTER IV
DISCUSSION
The following chapter provides a review of the major findings from this
study as well as implications for future work and research in the ME/CFS field.
Limitations of the study are also identified and recommendations for future
research in this area are presented.
Major Findings and Implications
The present study served as an investigation of the impact of contextual
factors (e.g. timeframe, symptom stability, and momentary symptom severity) on
the test-retest reliability of ME/CFS symptom composite scores (frequency
multiplied by severity) across two assessment points. Results of hypothesis I,
which tested the impact of symptom stability on reliability, revealed that symptom
stability significantly and positively impacted test-retest reliability for postexertional malaise (PEM), headaches, and memory problems, such that the more
stable the symptom was perceived to be over time, the better participants‟
symptoms scores at interview one were in predicting scores at interview two.
Prior research supports the finding that greater stability can improve recall
(Stone & Shiffman, 2002; Stull et al., 2009); however, it is unclear why this
impact of stability was found for some and not all ME/CFS symptoms. These
differential findings suggest that symptom stability can have a significant impact
on the reliability of symptom reporting and that the size of the impact may depend
on symptom type. Based on these findings, it is important for researchers and
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health care professionals to take into account the potential impact of stability on
symptom experience.
Results of hypothesis II revealed that increases in the momentary severity
scores for concentration problems and sore throats across the two interviews,
significantly predicted increases in concentration and sore throat composite scores
at interview two when the reference group was the six month timeframe. These
results were not observed at the other two timeframes (e.g. past week and past
month) or for any of the additional ME/CFS symptoms measured.
Prior research has shown that mood, attitude, and health status at the time
of an assessment can impact recall (Blaney, 1986; Broderick, Eich et al., 1985;
Schwartz, Shiffman, Hufford, & Stone, 2003; Stull et al., 2009). Specifically,
Eich et al. found that respondents with increased pain at the time of an assessment
were more likely to recall their past pain symptoms as more severe than they had
originally reported (1985). Based on this research, it was expected that
momentary symptom severity would have a wider impact on the reliability of
symptom reports assessed at the longer timeframes (past week, past month, past
six months). Results of the present study suggest that for the majority of ME/CFS
symptoms, the reliability of the composite scores are not largely affected by
momentary symptom severity. Sore throats and concentration problems however,
do appear to be impacted by a person‟s momentary status. It is unsurprising that
an increase over the course of one week in momentary concentration severity
could influence a persons‟ ability to reliably recall their concentration scores at
the longer timeframes. It is possible that this impact on reliability is due to the fact
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that people are having difficulty concentrating on what the question is asking
them; thus having difficulty reliably recalling their concentration problems over
the longer timeframe. Alternatively people may be using cognitive heuristics by
adjusting their concentration problems as worse at the longer timeframes because
it is experienced as more severe in the moment. Results showed that the shift in
scores at the longer timeframes were in the same positive direction as the
momentary changes in score, suggesting that the latter explanation is plausible.
One possible explanation for why changes in momentary sore throat
severity impact recall at the six month period, is that the majority of participants
rated their sore throat scores as variable over the six month period (see Table 2
and Table 3) and this instability in symptom experience may make sore throats
more susceptible to cognitive biases. For instance, Bradburn, Rips, and Shevell
(1987), and Bradburn (2000) assert that when respondents are asked to report on
highly fluctuating symptoms at a longer timeframe, they are more likely to use
cognitive heuristics for this highly complex task. Furthermore, these adjustments
and short-cuts may be more susceptible to contextual factors such as momentary
severity. As the recall timeframe gets longer, the task becomes more complex for
the respondent, and it becomes more likely that a respondent will rely on
cognitive short-cuts to answer the question; thus providing a possible explanation
for why changes in momentary severity only significantly impacted symptom
reports at the six month timeframe rather than the past month or past week. Given
these findings, it may be important for researchers and physicians to take into
account current health status when acquiring retrospective reports of certain
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symptoms, especially when symptoms are highly fluctuating or reported over a
longer timeframe.
Results of research question Ia revealed that the optimal timeframe for
ME/CFS symptoms perceived as variable over time, differed across symptoms.
The past six months was observed as the optimal timeframe for five of the nine
symptoms measured (e.g. sore throat, lymph node, muscle pain, headaches, and
concentration) whereas the past month was observed to be optimal for reporting
PEM, unrefreshing sleep, and memory problems. Lastly, the past week timeframe
was found to be optimal for variable joint pain. While an optimal timeframe could
be identified for each ME/CFS symptom, it is important to note that four
symptoms (e.g. PEM, headache, memory, and concentration) had relatively weak
slope coefficients, suggesting that when these symptoms are perceived as variable
over time, they are not reliably recalled from one week to another. PEM and
cognitive difficulties including memory and concentration problems are often
cited as cardinal symptoms of the illness ME/CFS (Carruthers et al., 2003; Jason
et al., 2010). Only five of the total 51 participants in this study reported that their
PEM was variable over time (See Table 2) and less than half of all participants
reported that memory and concentration was variable (19 and 16 respectively; see
Table 2). It is possible that when key symptoms of this illness are experienced as
variable and fluctuating, they are more difficult to recall consistently. It is also
possible that individuals who report these symptoms as variable my represent a
unique subset. The majority of participants reported headaches as variable over
time (31 out of 47; see Table 2 and Table 3); however the optimal slope
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coefficient for this symptom was still weak at .32 suggesting that headaches have
poor recall reliability when perceived as variable over time. These findings may
be explained by the tendency for people to use cognitive heuristics when
assessing variable symptoms over a longer timeframe; which in turn affects
reliability and accuracy of reporting (Bradburn, Rips, & Shevell, 1987; Bradburn,
2000). Due to the fact that the majority of the study population reported their
headaches as variable, it is recommended that researchers and physicians be
knowledgeable of the fluctuating nature of this symptom as well as the weak
reliability in reporting the frequency and severity of this symptom over long time
periods.
Results of research question Ib (supplementary) revealed that the optimal
timeframe in terms of test-retest reliability for ME/CFS symptoms perceived as
stable over time was highly uniform, such that all nine ME/CFS symptoms were
more reliably recalled at the six month timeframe compared to the past week and
past month timeframes. Stable sore throats had the weakest slope coefficients at
all three timeframes compared to the other eight symptoms, suggesting that sore
throats are not as reliably recalled when perceived as stable over time.
Interestingly, the optimal slope coefficient for variable sore throats was higher
than the optimal slope coefficient for stable sore throats. It is unclear why sore
throats are recalled more consistently when variable and at the past six month
timeframe. Sore throats are not widely considered a cardinal symptom of
ME/CFS, which is supported by this study data, showing that only 38 of the total
51 participants reported experiencing sore throats over the course of their illness
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and 58.8 percent of these respondents reported their sore throats as variable rather
than stable over time. Stone and colleagues (2002) assert that when a respondent
reports about a highly variable symptom, they are making an overall assessment
of their experience, and cannot indicate the variable nature of the symptom in a
short time period. However, when highly variable symptoms are reported over
longer timeframes, an individual will attempt to summarize their experience.
Summarizing variable events over a long timeframe has been found to reduce
reporting accuracy (Stone, Schwartz, Broderick, & Shiffman, 2005); however, in
the case of this study, when reporting on particular symptoms, such as sore throats
over longer timeframes, variability may actually improve recall reliability.
Results of research question II revealed that in the absence of contextual
factors (e.g. stability, momentary severity), recall reliability across timeframe
does not differ by symptom type. This is supported by the results of the
supplementary research question III, which showed that in the absence of
contextual factors (symptom stability and momentary severity), the optimal
timeframe for reliably reporting ME/CFS symptoms appeared to be six months
for all but one symptom (e.g. joint pain), which had an optimal timeframe of one
month. While past literature shows a reduction in reporting accuracy when using
longer recall timeframes, the results of this study show that longer timeframes
may actually improve reliability. As mentioned previously, individuals with
chronic illnesses may have a good grasp of their symptom pattern over time
(Broderick et al., 2008), which may at least partially explain why individuals in
this study were able to reliably make a global assessment of their symptoms at the
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six month timeframe. People afflicted with a chronic illness such as ME/CFS may
be more reliable in making a broad and global estimate of their symptoms over a
longer timeframe because the shorter timeframe may be more susceptible to small
changes that deviate from the normal symptom pattern. Clarke et al. (2008) assert
that there is a tradeoff between reporting accuracy and loss of information when
deciding between a shorter or longer recall timeframe. Short timeframes may
increase the accuracy of recall, but investigators risk losing valuable information
about the true nature of the phenomena that would be better captured with a
longer recall period. More work is needed in this area in order to determine if the
six month timeframe is optimal in understanding the experience of ME/CFS
symptoms.
Limitations of Research
There are notable limitations of the current study. The study sample used
was not selected through random assignment and thus participants may share
certain characteristics that are different from the larger population of individuals
affected by ME/CFS. For instance, a large majority of the participants were White
women and middle aged. Based on research by Jason and colleagues (1999) we
know that CFS occurs at higher rates in African American and Latino samples;
therefore, the current sample may not be generalizable to the entire ME/CFS
population.
Another limitation of this study was the uneven frequency of stable versus
variable ratings for certain symptoms. These symptoms were either unevenly
rated as stable (e.g. PEM) or variable (e.g. sore throat). Kahn (2011) asserts that
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establishing a rule of thumb for sample size in achieving statistical power can be
difficult because it is important to take sample size into consideration at two
levels of data. Kahn reports that a large number of cases in each group improve
reliability of Level 1 estimates. Monte Carlo research conducted by Maas and
Hox (2005) reveal that samples with at least 30 Level 2 units provide sufficiently
unbiased estimates; however, they also report that samples with only 10 Level 2
units maybe also be sufficient. The majority of symptom cases in this study met
the 10 unit limit at the level 2 grouping. However, even when there are 30 units in
the Level 2 grouping, the variance components will be biased. Therefore, Kahn
argues that the more cases at Level 2, the better. This concern of sample size at
Level 2 and the subsequent impact on power is most prominent for PEM and sore
throats, which have very uneven stable versus variable ratings and also have
groups with cases below 10.
Lastly, another possible limitation of this study is the potential for the
“adjustment and anchoring” heuristic (Tversky & Kahneman, 1974) in
influencing recall reliability across the timeframes. The adjustment and anchoring
effect explains how people take information that they know and use that
information as an anchor to help estimate information that they do not know.
Steen et al. (1994) showed that individuals rating their asthma symptoms over a
three month timeframe, first rated their asthma over the past month and used this
rating as an anchor in order to estimate their asthma over the three month
timeframe. It is possible that this anchoring effect was present in the current
study; however, in an attempt to control this effect, the timeframes were spaced
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out so that symptom ratings were not organized by symptom groupings but rather
by timeframe groupings. For example, participants did not rate their sore throats
at each timeframe all at once, but rather participants rated all nine symptoms at
the first timeframe (right now) and then all nine symptoms at the second
timeframe (past week) and so on. (see Appendix A for a visual representation of
the questionnaire). By not positioning the different timeframes directly after the
other for each symptom, it seems likely that the tendency for “adjustment and
anchoring” heuristics is greatly reduced.
Conclusion and Future Directions
Overall, findings from the presented study reveal that contextual factors
do influence the reliability of reporting ME/CFS symptoms; however, not as
dramatically as might be expected. Furthermore, the degree of impact that these
contextual factors have on test-retest reliability may depend on the ME/CFS
symptom being measured as well as individual characteristics of the respondent.
Furthermore, results showed that in general, individuals with this illness are
capable of reliably recalling the frequency and severity of their symptoms over
longer timeframes (e.g. six months), which is contrary to what might be expected
based on literature documenting reduced accuracy of reports using longer
timeframes.
It is recommended that future research in this area explore the potential
tradeoff between reduced reporting accuracy and gaining more information about
a phenomenon using longer timeframes. For instance, one way of assessing the
validity of the longer six-month timeframe is by comparing the degree of
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convergent validity that symptom scores measured at longer timeframes have with
other diagnostic measures. One criterion that is necessary for receiving a
diagnosis of ME/CFS is the experience of substantial reductions in occupational,
social, and personal activities (Fukuda, et al., 1994). Future research might assess
the degree to which symptom ratings at each timeframe correlate with or predict
measures of substantial reduction.
In terms of the influence of contextual factors, it may also be conducive to
understand additional factors that influence the reliability of symptom reporting.
These additional factors may include recent stressful life events, social support, or
the participants‟ stage/progression of illness. Participants of the current study
answered questions regarding recent life events, stress, and additional health
factors on the significant events questionnaire. Although these issues were not
explored for the purposes of the present paper, these potentially influential factors
will be explored in future research.
In sum, timeframe, symptom stability, and momentary severity do appear
to influence the reliability in reporting ME/CFS symptoms. Furthermore, in the
absence of stability and momentary severity, individuals were most reliable in
reporting the majority of the nine ME/CFS symptoms over a six month
timeframe. It will be important for researchers who are interested in the
assessment of ME/CFS to take these contextual factors into account, especially if
the intended goal of the research is in standardizing and improving the methods
used to reliably and accurately diagnose this complex illness. Accurate and
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reliable assessment is a crucial first step in understanding and treating this
debilitating and often misunderstood illness.
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CHAPTER V
SUMMARY
Retrospective self report measures are often used in research and
diagnostic assessment of myalgic encephalomyelitis/chronic fatigue syndrome
(ME/CFS) (Hawk, Jason, & Torres-Harding, 2007; Jason, King, Frankenberry, &
Jordan, 1999; King & Jason, 2005; Reeves et al., 2005). These retrospective selfreport measures are susceptible to recall bias, which has the potential to impact
the reliability and validity of diagnostic decisions. One factor that can influence
the magnitude of recall bias in symptom reporting, is the length of the recall
timeframe used. Previous research has found that recall bias may increase when
longer reporting periods are used, but very little research has been done on this
area (Broderick et al., 2008), making it unclear what the optimal reporting period
is for tracking health symptoms, especially for a complex chronic illness such as
ME/CFS.
In order to contribute to the literature on the effects of timeframe length on
symptom recall in individuals with ME/CFS, this study served as an investigation
of the reliability of symptom data assessed at three recall timeframes (the past
week, the past month, and the past six months) and at two assessment points (with
one week in between each assessment). Symptoms that are experienced as more
stable in nature have been found to be recalled with greater accuracy than
symptoms that are highly fluctuating and variable; therefore, it was predicted that
the test-retest reliability of ME/CFS symptoms measured at the different recall
timeframes would be strongest for those symptoms that are stable overtime. This
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hypothesis was supported for only three of the nine ME/CFS symptoms measured
(e.g. post-exertional malaise, headaches, and memory).
Another aim of the study was to investigate the influence that an
individual‟s current symptom severity has on symptom recall at longer
timeframes. It was predicted that an increase (worsening) in momentary symptom
severity ratings from baseline to assessment two, would predict an increase in the
recall of symptom frequency and severity scores at longer timeframes. Similarly,
it was expected that a decrease in momentary symptom severity ratings from
week one to week two would result in a decrease in recall for symptom frequency
and severity scores at longer timeframes. This hypothesis was only supported for
two of the nine symptoms (e.g. sore throats and concentration problems) when the
reference group was six months.
In order to further understand the influence of symptom stability on recall
reliability, the present study investigated the optimal recall timeframe for
symptoms rated as variable versus symptoms rated as stable. Results suggested
that the optimal timeframe for variable ME/CFS symptoms differed across
symptoms, such that, the past six months was observed as the optimal timeframe
for five of the nine symptoms measured (e.g. sore throat, lymph node, muscle
pain, headaches, and concentration), whereas the past month was observed to be
optimal for reporting PEM, unrefreshing sleep, and memory problems. Lastly,
the past week timeframe was found to be optimal for variable joint pain. Results
revealed that the optimal timeframe for reliably reporting stable ME/CFS
symptoms is highly uniform, such that all nine ME/CFS symptoms measured

69

were more reliably recalled at the six month timeframe compared to the past week
and past month timeframes. In the absence of contextual factors (e.g. stability,
momentary severity), recall reliability across timeframes did not differ by
symptom type. Supplemental analyses revealed that in the absence of the
contextual factors mentioned above, the optimal timeframe for reliably reporting
ME/CFS symptoms appear to be six months for all but one symptom (e.g. joint
pain), which had an optimal timeframe of one month.
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Appendix B
Symptom Stability Survey
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Interviewer Script: Now I am going to ask you about the stability of your health
symptoms. For each symptom I say out loud, please say “yes” if you have
experienced the symptom over the past 6 months.

AND

If you have experienced the symptom, please tell me whether the symptom has been
constant
or if it has been fluctuating and inconsistent over the past 6 months
A symptom that is constant is one that occurs regularly and does not change much in
how bad or severe it is over time.
A symptom that is fluctuating and inconsistent is one that does not occur regularly
and there is no pattern to how bad or severe it is.
More Examples:
A constant symptom is one that is experienced every week or every day and with the
same intensity or severity
A fluctuating symptom is one that is experienced some weeks but not others and there
is no pattern to how often it is experienced or how bad it is experienced
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Appendix C
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Table 7
Means and Standard Deviations of Symptom Severity Scores on the SI-R
at Interviews 1 and 2, N=51

Symptom
Sore Throat

Lymph Nodes

Post Exertional
Malaise (PEM)

Muscle Pain

Joint Pain

Unrefreshing Sleep

Headaches

Memory Problems

Difficulty
Concentrating

Timeframe
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months
Now
Week
Month
Six Months

Interview 1
M (SD)
0.75 (1.11)
1.51 (1.39)
1.60 (1.29)
2.04 (1.35)
1.16 (1.24)
1.82 (1.41)
1.84 (1.43)
6.43 (6.86)
3.45 (1.25)
3.86 (0.69)
3.90 (0.64)
4.10 (0.67)
2.84 (1.21)
3.18 (0.91)
3.14 (1.08)
3.29 (1.06)
2.20 (1.54)
2.45 (1.38)
2.57 (1.35)
2.63 (1.48)
3.78 (1.22)
3.78 (0.90)
3.71 (0.90)
3.75 (1.07)
1.41 (1.49)
2.45 (1.42)
2.67 (1.28)
2.84 (1.39)
2.31 (1.57)
2.96 (0.10)
2.94 (1.01)
3.02 (1.03)
2.69 (1.17)
3.29 (0.88)
3.22 (0.83)
3.37 (0.96)

Interview 2
M (SD)
0.92 (1.15)
1.53 (1.46)
1.51 (1.27)
1.92 (1.43)
1.24 (1.45)
1.63 (1.46)
1.76 (1.35)
5.45 (5.75)
3.57 (1.25)
3.94 (0.73)
3.86 (0.63)
3.90 (0.61)
2.78 (1.22)
3.06 (0.93)
3.10 (0.94)
3.10 (0.85)
2.20 (1.48)
2.66 (1.33)
2.57 (1.25)
2.69 (1.29)
3.61 (1.25)
3.84 (0.92)
3.61 (0.90)
3.69 (0.99)
1.25 (1.47)
2.47 (1.43)
2.45 (1.22)
2.78( 1.19)
2.24 (1.49)
2.84 (1.24)
2.84 (1.10)
3.00 (1.15)
2.84 (1.27)
3.20 (1.06)
3.18 (0.91)
3.31 (0.99)

